Alx Oncology Holdings (ALXO) Tax Rate (2019 - 2020)
Alx Oncology Holdings' (ALXO) quarterly Tax Rate came in at 1.04% in Q4 2020, up 115.0% year-on-year from 0.49% in Q1 2020, and up 402.34% quarter-over-quarter from 0.34% in Q3 2020.
Alx Oncology Holdings (ALXO) Tax Rate (2019 - 2020) Analysis & Trends
Alx Oncology Holdings has disclosed Tax Rate across 2 years of filings, most recently posting 1.04% for Q4 2020.
- Tax Rate for Q4 2020 came in at 1.04%, up 115.0% year-over-year; the trailing twelve-month figure through Dec 2020 was 2.55% (changed N/A YoY), and the FY2022 annual result was 0.53%, down 57.0% from the prior year.
- Tax Rate came in at 1.04% for Q4 2020 at Alx Oncology Holdings, up from 0.34% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 1.04% in Q4 2020 to a low of 0.34% in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -57.14% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 5.61% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -6.79% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 17.68% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Alx Oncology Holdings | 166.27 Mn | 25.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.04% |
| Dec 31, 2020 | 1.04% |
| Sep 30, 2020 | -0.34% |
| Sep 30, 2020 | -0.34% |
| Jun 30, 2020 | -0.18% |
| Jun 30, 2020 | -0.18% |
| Mar 31, 2020 | -0.07% |
| Mar 31, 2020 | -0.07% |
| Dec 31, 2019 | -0.11% |
| Dec 31, 2019 | -0.11% |
| Sep 30, 2019 | -0.26% |
| Sep 30, 2019 | -0.26% |
| Jun 30, 2019 | -0.19% |
| Jun 30, 2019 | -0.19% |